
Bal Pharma Limited has informed the Exchange about press release dated 16-Nov-2022 titled Bal Pharma Ltd announces resilient Q2 results against price volatility and intense API competition.
Filed with NSE ·

Bal Pharma Limited has informed the Exchange about press release dated 16-Nov-2022 titled Bal Pharma Ltd announces resilient Q2 results against price volatility and intense API competition.
6ix hasn’t read this filing yet.
Follow Bal Pharma into a list and get an email when it puts out news.
Follow Bal Pharma